Several studies demonstrated that the selective TRPC6 activator hyperforin reduces Aβ levels and improves behavioral performance in Alzheimer’s disease (AD) animal models and in vitro studies [46]. The gene discussed is TRPC6; the disease is early-onset autosomal dominant Alzheimer disease.